Figure 2From: High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy Distant metastases free survival (DMFS) (a) and Overall survival (OS) (b) according to pretreatment survivin expression (low survivin: weighted score ≤ 8; high survivin: weighted score > 8). Back to article page